Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
Cancer Immunology, Immunotherapy · 2024
DOI: 10.1007/s00262-024-03849-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Tomoko Ohtani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, …. Hauptthemen laut MEDLINE: Dendritic Cells, Exosomes, Oncolytic Viruses, Adenoviridae. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Okayama University.
Abstract (Originalsprache)
Dendritic cells (DCs) are crucial in cancer immunity, because they activate cytotoxic T cells by presenting tumor antigens. Recently, oncolytic virus therapy has been recognized as a systemic immune stimulator. We previously developed a telomerase-specific oncolytic adenovirus (OBP-301) and a p53-armed OBP-301 (OBP-702), demonstrating that these viruses strongly activate systemic antitumor immunity. However, their effects on DCs remained unclear. In the present study, the aim was to elucidate the mechanisms of DC activation by OBP-702, focusing particularly on tumor-derived exosomes. Exosomes (Exo53, Exo301, or Exo702) were isolated from conditioned media of human or murine pancreatic cancer cell lines (Panc-1, MiaPaCa-2, and PAN02) after treatment with Ad-p53, OBP-301, or OBP-702. Exo702 derived from Panc-1 and MiaPaCa-2 cells significantly upregulated CD86, CD80, CD83 (markers of DC maturation), and IFN-γ in DCs in vitro. Similarly, Exo702 derived from PAN02 cells upregulated CD86 and IFN-γ in bone marrow-derived DCs in a bilateral PAN02 subcutaneous tumor model. This DC maturation was inhibited by GW4869, an inhibitor of exosome release, and anti-CD63, an antibody targeting the exosome marker. Intratumoral injection of OBP-702 into PAN02 subcutaneous tumors significantly increased the presence of mature DCs and CD8-positive T cells in draining lymph nodes, leading to long-lasting antitumor effects through the durable activation of systemic antitumor immunity. In conclusion, tumor-derived exosomes play a significant role in DC maturation following OBP-702 treatment and are critical for the systemic activation of antitumor immunity, leading to the abscopal effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
- Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. shinkuro@okayama-u.ac.jp.
- Minimally Invasive Therapy Center, Okayama University Hospital, Okayama, Japan. shinkuro@okayama-u.ac.jp.
- Minimally Invasive Therapy Center, Okayama University Hospital, Okayama, Japan.
- Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
- Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Okayama University
Zitieren
APA
Ohtani, T., Kuroda, S., Kanaya, N., Kakiuchi, Y., Kumon, K., Hashimoto, M., Yagi, C., Sugimoto, R., Kikuchi, S., Kagawa, S., Tazawa, H., Urata, Y., & Fujiwara, T. (2024). Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03849-5
Vancouver
Ohtani T, Kuroda S, Kanaya N, Kakiuchi Y, Kumon K, Hashimoto M, et al. Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03849-5
BibTeX
@article{Ohtani2024,
author = {Ohtani, Tomoko and Kuroda, Shinji and Kanaya, Nobuhiko and Kakiuchi, Yoshihiko and Kumon, Kento and Hashimoto, Masashi and Yagi, Chiaki and Sugimoto, Ryoma and Kikuchi, Satoru and Kagawa, Shunsuke and Tazawa, Hiroshi and Urata, Yasuo and Fujiwara, Toshiyoshi},
title = {Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
doi = {10.1007/s00262-024-03849-5}
}
EUVIMED